4Front Ventures Corp. (FFNTF) financial statements (2022 and earlier)

Company profile

Business Address 2900-550 BURRARD STREET
VANCOUVER, BC V6C 0A3
State of Incorp. BC
Fiscal Year End December 31
SIC 2833 - Medicinal Chemicals and Botanical Products (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2021
TTM
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 18,932
Cash and cash equivalents 18,932
Receivables 5,492
Inventory, net of allowances, customer advances and progress billings 18,037
Inventory 18,037
Prepaid expense 2,275
Total current assets: 44,736
Noncurrent Assets
Operating lease, right-of-use asset 62,466
Nontrade receivables 7,595
Property, plant and equipment 33,618
Long-term investments and receivables 91
Accounts and financing receivable, after allowance for credit loss 91
Intangible assets, net (including goodwill) 51,945
Goodwill 23,155
Intangible assets, net (excluding goodwill) 28,790
Deposits noncurrent assets 4,305
Total noncurrent assets: 160,020
TOTAL ASSETS: 204,756
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 16,224
Accounts payable 4,722
Taxes payable 11,502
Debt 5,024
Derivative instruments and hedges, liabilities 5,807
Business combination, contingent consideration, liability 2,393
Other undisclosed current liabilities 8,336
Total current liabilities: 37,784
Noncurrent Liabilities
Long-term debt and lease obligation 113,536
Long-term debt, excluding current maturities 61,991
Operating lease, liability 51,545
Liabilities, other than long-term debt 9,633
Deferred income tax liabilities 6,530
Business combination, contingent consideration, liability 3,103
Other undisclosed noncurrent liabilities 1,600
Total noncurrent liabilities: 124,769
Total liabilities: 162,553
Stockholders' equity
Stockholders' equity attributable to parent, including: 42,151
Additional paid in capital 42,116
Accumulated deficit (250,548)
Other undisclosed stockholders' equity attributable to parent 250,583
Stockholders' equity attributable to noncontrolling interest 52
Total stockholders' equity: 42,203
TOTAL LIABILITIES AND EQUITY: 204,756

Income statement (P&L) ($ in thousands)

9/30/2021
TTM
12/31/2020
Revenues 57,635
Other undisclosed gross profit (21,124)
Gross profit: 36,511
Operating expenses (69,121)
Operating loss: (32,610)
Nonoperating income 81
Investment income, nonoperating (682)
Other nonoperating income 763
Interest and debt expense (14,181)
Loss from continuing operations before equity method investments, income taxes: (46,710)
Other undisclosed income from continuing operations before income taxes 1,767
Loss from continuing operations before income taxes: (44,943)
Income tax expense (15,049)
Loss from continuing operations: (59,992)
Income from discontinued operations 12,987
Net loss: (47,005)
Net loss attributable to noncontrolling interest (46)
Net loss available to common stockholders, diluted: (47,051)

Comprehensive Income ($ in thousands)

9/30/2021
TTM
12/31/2020
Net loss: (47,005)
Comprehensive loss: (47,005)
Comprehensive loss, net of tax, attributable to noncontrolling interest (46)
Comprehensive loss, net of tax, attributable to parent: (47,051)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: